| 1 |
33070471 | Altered third-party punishment in Huntington's disease: A study using neuroeconomic games. | 2021 Jan |
1 |
| 2 |
34911927 | Small molecule splicing modifiers with systemic HTT-lowering activity. | 2021 Dec 15 |
2 |
| 3 |
32548276 | Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. | 2020 Jun |
2 |
| 4 |
32686867 | Clinical Outcomes and Selection Criteria for Prodromal Huntington's Disease Trials. | 2020 Dec |
2 |
| 5 |
32784364 | Subcortical T1-Rho MRI Abnormalities in Juvenile-Onset Huntington's Disease. | 2020 Aug 8 |
1 |
| 6 |
33049985 | Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington's Disease Status Based on Omics Data. | 2020 Oct 8 |
2 |
| 7 |
33209959 | Investigational Assay for Haplotype Phasing of the Huntingtin Gene. | 2020 Dec 11 |
1 |
| 8 |
30563778 | Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study. | 2019 Feb |
1 |
| 9 |
30632085 | Protective Effects of Antioxidants in Huntington's Disease: an Extensive Review. | 2019 Apr |
2 |
| 10 |
31304621 | Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease. | 2019 Nov |
3 |
| 11 |
31727211 | The psychopharmacology of Huntington disease. | 2019 |
1 |
| 12 |
29377621 | Potassium channel dysfunction in neurons and astrocytes in Huntington's disease. | 2018 Apr |
2 |
| 13 |
29898922 | Epigenetic alterations mediate iPSC-induced normalization of DNA repair gene expression and TNR stability in Huntington's disease cells. | 2018 Jul 6 |
1 |
| 14 |
30679892 | Mitochondrial distribution violation and nuclear indentations in neurons differentiated from iPSCs of Huntington's disease patients. | 2018 |
2 |
| 15 |
27740685 | Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS). | 2017 Jun |
1 |
| 16 |
28585930 | Large normal-range TBP and ATXN7 CAG repeat lengths are associated with increased lifetime risk of depression. | 2017 Jun 6 |
2 |
| 17 |
29225330 | Huntingtin gene repeat size variations affect risk of lifetime depression. | 2017 Dec 11 |
1 |
| 18 |
27481337 | Modeling Variability in the Progression of Huntington's Disease A Novel Modeling Approach Applied to Structural Imaging Markers from TRACK-HD. | 2016 Aug |
1 |
| 19 |
25290828 | Challenges of Huntington's disease and quest for therapeutic biomarkers. | 2015 Feb |
2 |
| 20 |
25847392 | Predicting cumulative risk of disease onset by redistributing weights. | 2015 Jul 20 |
2 |
| 21 |
26443925 | Abnormal Weight and Body Mass Index in Children with Juvenile Huntington's Disease. | 2015 |
1 |
| 22 |
23557875 | Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression. | 2013 Jul |
2 |
| 23 |
23853009 | Huntington's disease masquerading as spinocerebellar ataxia. | 2013 Jul 12 |
1 |
| 24 |
23906595 | Prefrontal executive function associated coupling relates to Huntington's disease stage. | 2013 Nov-Dec |
2 |
| 25 |
23953200 | Raman spectroscopy and partial least squares analysis in discrimination of peripheral cells affected by Huntington's disease. | 2013 Sep 2 |
4 |
| 26 |
22138129 | Antioxidants in Huntington's disease. | 2012 May |
2 |
| 27 |
22649062 | Brain metabolite alterations and cognitive dysfunction in early Huntington's disease. | 2012 Jun |
1 |
| 28 |
22974690 | Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex. | 2012 Aug-Sep |
2 |
| 29 |
23440000 | Intermediate CAG Repeats in Huntington's Disease: Analysis of COHORT. | 2012 |
2 |
| 30 |
20649476 | Derivation of Huntington's disease-affected human embryonic stem cell lines. | 2011 Mar |
2 |
| 31 |
20802793 | Altered cholesterol and fatty acid metabolism in Huntington disease. | 2010 Jan-Feb |
1 |
| 32 |
18488016 | Towards a transgenic model of Huntington's disease in a non-human primate. | 2008 Jun 12 |
2 |
| 33 |
18588526 | Mechanisms of neurodegeneration in Huntington's disease. | 2008 Jun |
2 |
| 34 |
16504973 | Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease. | 2006 May |
1 |